US FTC amends suit against Walmart for allegedly allowing money transfer services for fraud

WASHINGTON (Reuters) – The U.S. Federal Trade Commission has filed an amended complaint alleging that Walmart Inc allowed scam artists to use the company’s money transfer services to defraud consumers, the commission said on Friday. The FTC filed the amended complaint in the U.S. District Court for the Northern District of Illinois, which in March…

Read More

Power grids not yet ready for ‘flying cars’, says Brazil’s Eve

By Gabriel Araujo SAO PAULO (Reuters) – Power grids around the world are not yet ready for the so-called flying car, an executive with Brazilian start-up Eve Air Mobility told Reuters, adding that the electric aircraft maker is in talks with power providers to bridge the gap. Eve’s Services & Operations Solutions Vice President, Luiz…

Read More

Exclusive-Prosecutors probe false accounting charges in Eurovita case – source

By Emilio Parodi MILAN (Reuters) – Prosecutors in Milan are probing allegations of false accounting in relation to the crisis at Italian life insurer Eurovita, a person with knowledge of the matter said on Friday. Owned by Cinven, Eurovita this year became the first Italian insurer to be placed under special administration by the country’s…

Read More

US urges appeals court to uphold Ghislaine Maxwell’s sex trafficking conviction

By Jonathan Stempel and Jack Queen NEW YORK (Reuters) -The U.S. government has urged an appeals court to uphold Ghislaine Maxwell’s conviction and 20-year prison sentence for helping the disgraced late financier Jeffrey Epstein sexually abuse teenage girls. In a Thursday night filing with the 2nd U.S. Circuit Court of Appeals in Manhattan, federal prosecutors…

Read More

Emerging markets carry investor hopes for H2 on lower inflation, rates

By Rodrigo Campos and Marc Jones NEW YORK/LONDON (Reuters) – From BlackRock to JPMorgan, some of the world’s top investors are upbeat on emerging markets for the second half of the year on the prospect of falling interest rates, while signs of progress in tricky debt talks are set to buoy frontier markets. Positive headlines…

Read More

Bausch + Lomb buys Novartis drugs for $1.75 billion to boost eye-care portfolio

(Reuters) – Bausch + Lomb said on Friday it would acquire several Novartis eye-care products for $1.75 billion as their market grows, sending the company’s shares up over 8% in early trading. The deal includes acquisition of Novartis’ anti-inflammation eye drop Xiidra, experimental drug libvatrep for chronic ocular surface pain, and rights to use the…

Read More